Last updated on October 2018

Global Multicentre Non Interventional Advagraf Conversion Registry in Kidney Transplant Patients

Brief description of study

A study to evaluate changes over time in renal function from baseline (time of conversion) up until five years post conversion in kidney transplant patients converted from tacrolimus twice daily (BD) formulations to a once daily formulation as Advagraf.

Detailed Study Description

This is a multicenter long-term (up to five years post-conversion), non-interventional registry in kidney transplant patients who have been converted from tacrolimus BD to Advagraf. Centers that are providing medical care for kidney transplant patients who may convert patients from tacrolimus BD to Advagraf will be identified and requested to approach patients for consent to participate.

Clinical Study Identifier: NCT02555787

Contact Investigators or Research Sites near you

Start Over

Medical Affairs Europe

Site AU6106
Gosford, Australia